A noted analyst has slashed his expectation for Apple stock by about 10% given what he sees to be slower iPhone upgrade rates ...

Microsoft (NASDAQ:MSFT) investors have been on edge lately, wondering whether the company’s AI growth could take a hit amid concerns about ...

After nearly doubling in value between Nov. 5 and Dec. 17 to hit $488 per share and give the electric vehicle maker a $1.6 ...

This week began with turbulent stock markets, shaken by recession fears and trade war concerns. Wall Street’s sell-off ...

Investors are digesting better-than-expected inflation data and bracing for the next move in Trump's escalating trade war.

Chipmaker Marvell Technology's (NASDAQ: MRVL) year went from bad to worse after the company released its fiscal 2025 ...

The stock market has gotten off to a very different start to the year than most investors might have imagined. The broader ...

Since the start of Donald Trump’s second term as US president, tech giants have seen their shares on the stock market tumble.

Morgan Stanley expects Dr. Agarwal's revenue and Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA) to ...

Morgan Stanley placed a target price of Rs 502 on Dr. Agarwal's Health Care stock, implying an upside potential of 17% to the previous close.

Every so often, a stock captures the imagination of investors like few others can. The company's technology promises to be so ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.